| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | Director | Ordinary Shares | 14,868 | $1,771,225 | $119.13 | 14 Aug 2023 | Direct |
| LANDEC CORP \CA\ | Director | Common Stock | 54,069 | $378,483 | $7.00 | 04 Jun 2022 | Direct |
| Altimmune, Inc. | Director | Common Stock, par value $0.0001 | 1,500 | $6,352 | $4.24 | 05 Jan 2026 | Direct |
| Maze Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $39.11 | 07 Jan 2026 | Direct |
| Altimmune, Inc. | Director | Stock Options (option to buy) | 48,800 | 25 Sep 2025 | Direct | ||
| Rubius Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25,000 | 12 May 2022 | Direct | ||
| Axcella Health Inc. | Director | Stock Option (Right to Buy) | 20,000 | 19 May 2022 | Direct | ||
| Maze Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 5,805 | 07 Jan 2026 | Direct | ||
| LANDEC CORP \CA\ | Director | Restricted Stock Unit | 0 | $7.00 | 04 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 06 Jan 2026 | 10 | -$842,571 | 4 | Director | 08 Jan 2026, 16:30 |
| ALT | Altimmune, Inc. | 05 Jan 2026 | 1 | +$2,118 | 4 | Director | 05 Jan 2026, 16:05 |
| ALT | Altimmune, Inc. | 25 Sep 2025 | 1 | $0 | 4 | Director | 29 Sep 2025, 16:21 |
| MAZE | Maze Therapeutics, Inc. | 22 Sep 2025 | 1 | $0 | 4 | Director | 24 Sep 2025, 16:19 |
| ALT | Altimmune, Inc. | 17 Mar 2025 | 1 | +$5,784 | 4 | Director | 18 Mar 2025, 16:15 |
| ALT | Altimmune, Inc. | 06 Feb 2025 | 1 | $0 | 4 | Director | 07 Feb 2025, 16:05 |
| MAZE | Maze Therapeutics, Inc. | 30 Jan 2025 | 0 | $0 | 3 | Director | 30 Jan 2025, 16:37 |
| ALT | Altimmune, Inc. | 26 Sep 2024 | 1 | $0 | 4 | Director | 30 Sep 2024, 18:33 |
| ALT | Altimmune, Inc. | 28 Sep 2023 | 1 | $0 | 4 | Director | 29 Sep 2023, 18:01 |
| JAZZ | Jazz Pharmaceuticals plc | 11 Aug 2023 | 2 | -$171,455 | 4 | Director | 15 Aug 2023, 19:02 |
| ALT | Altimmune, Inc. | 23 Mar 2023 | 1 | $0 | 4 | Director | 27 Mar 2023, 16:17 |
| ALT | Altimmune, Inc. | 23 Mar 2023 | 0 | $0 | 3 | Director | 27 Mar 2023, 16:15 |
| JAZZ | Jazz Pharmaceuticals plc | 05 Aug 2022 | 2 | -$165,880 | 4 | Director | 09 Aug 2022, 18:44 |
| LFCR | LANDEC CORP \CA\ | 04 Jun 2022 | 2 | $0 | 4 | Director | 07 Jun 2022, 17:16 |
| LFCR | LANDEC CORP \CA\ | 31 May 2022 | 1 | $0 | 4 | Director | 02 Jun 2022, 12:46 |
| /report/000110465922063913-sohn-catherine-a-2022-05-19 | Axcella Health Inc. | 19 May 2022 | 1 | $0 | 4 | Director | 23 May 2022, 16:56 |
| /report/000117911022003004-sohn-catherine-a-2022-05-12 | Rubius Therapeutics, Inc. | 12 May 2022 | 1 | $0 | 4 | Director | 13 May 2022, 16:26 |
| JAZZ | Jazz Pharmaceuticals plc | 06 Aug 2021 | 1 | -$193,236 | 4 | Director | 10 Aug 2021, 17:40 |
| JAZZ | Jazz Pharmaceuticals plc | 29 Jul 2021 | 1 | $0 | 4 | Director | 02 Aug 2021, 18:28 |
| LFCR | LANDEC CORP \CA\ | 04 Jun 2021 | 1 | $0 | 4 | Director | 08 Jun 2021, 20:04 |
| LFCR | LANDEC CORP \CA\ | 01 Jun 2021 | 2 | $0 | 4 | Director | 03 Jun 2021, 20:03 |
| /report/000110465921071353-sohn-catherine-a-2021-05-20 | Axcella Health Inc. | 20 May 2021 | 1 | $0 | 4 | Director | 24 May 2021, 17:19 |
| /report/000117911021005315-sohn-catherine-a-2021-05-12 | Rubius Therapeutics, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 13 May 2021, 20:35 |